文献速递肺结节与肺癌

1.1毫米冷冻探头经支气管冷冻活检用于肺癌NGS分析

Next-generation sequencing using tissue specimen collected with a 1.1 mm-diameter cryoprobe in patients with lung cancer.
PubMed 文献 · Respirology · 2024-02-20

本研究回顾性纳入56例肺癌患者,评估使用1.1毫米直径冷冻探头经支气管冷冻活检(TBC)获取的组织标本进行下一代测序(NGS)的可行性。结果显示DNA和RNA测序的诊断率均为95%(53/56),98%患者为晚期肺癌,3例(5%)发生中度出血,无气胸或肺部感染等危及生命的并发症。结论认为该技术是NGS分析安全有用的工具。

要点

  • 1.1毫米冷冻探头TBC获取的肺癌组织可用于NGS的DNA和RNA测序。
  • NGS诊断率DNA和RNA均为95%(53/56)。
  • 中度出血发生率5%(3/56),无气胸或肺部感染等严重并发症。

核心结论

  • 使用1.1毫米直径冷冻探头的经支气管冷冻活检是适用于DNA和RNA测序NGS分析的安全有用工具。

研究设计与样本

  • 使用4.0或3.0毫米直径支气管镜,结合径向支气管内超声和虚拟支气管镜导航检测外周肺病变,所有操作在透视引导下进行。

主要发现

  • 56例患者中98%为晚期肺癌(III或IV期复发或不可手术疾病)。
  • NGS对DNA和RNA测序的诊断率均为95%(53/56)。
  • 3例(5%)出现中度出血,无患者发生气胸或肺部感染等危及生命的并发症。

临床怎么用

  • 对于晚期肺癌患者,可考虑使用1.1毫米冷冻探头TBC获取组织进行NGS检测,DNA和RNA测序诊断率均较高且严重并发症少见。

局限性

  • 回顾性研究设计。
  • 样本量有限(56例)。
  • 多数患者为晚期肺癌,结果推广至早期患者需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVE: Next-generation sequencing (NGS) analysis is considered standard for lung cancer diagnosis in clinical practice. Little is known about the feasibility of NGS using tumour tissue sampled with a 1.1 mm-diameter cryoprobe. We aimed to investigate the suitability of specimens obtained by transbronchial cryobiopsy (TBC) using a 1.1 mm-diameter cryoprobe for NGS analysis. METHODS: Patients with lung cancer who underwent TBC using a 1.1 mm-diameter cryoprobe for NGS testing between October 2020 and April 2023 were enrolled. A 4.0- or 3.0 mm-diameter bronchoscope with radial probe endobronchial ultrasound and virtual bronchoscopic navigation was used to detect peripheral lung lesions. All procedures were performed under fluoroscopic guidance. Data were analysed retrospectively. RESULTS: A total of 56 patients underwent TBC using a 1.1 mm cryoprobe for NGS testing, during the study period. Most patients (98%) were in the advanced stage of lung cancer (recurrent or inoperable disease of stages III or IV). The diagnostic yield of NGS for DNA and RNA sequencing was 95% each (53 of 56). Moderate bleeding was noted in three patients (5%) and none of the study patients developed life-threatening complications, such as pneumothorax or lung infection. CONCLUSION: TBC using a 1.1 mm-diameter cryoprobe is a useful and safe tool for NGS analysis, for both DNA and RNA sequencing.

来源:Respirology,查看原文。版权归原作者所有。

引用

  1. Kim MH, Kim SH, Lee G, et al. Next-generation sequencing using tissue specimen collected with a 1.1 mm-diameter cryoprobe in patients with lung cancer. Respirology. 2024. PMID: 38379178. doi:10.1111/resp.14680

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。